跳至主要内容
临床试验/PACTR202008851772042
PACTR202008851772042尚未招募1 期

ovel nanotechnology-based hemostatic dressing; A proof-of-concept clinical trial

Prof. Mostafa Hamad0 个研究点目标入组 30 人开始时间: 2020年6月19日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • patients undergoing different surgery that may lead to bleeding during the steps of the operation.
  • patients with bleeding severity either moderate or severe according to the mentioned severity score.

排除标准

  • Patients with bleeding disorders.
  • Patients with intra-operative disorders that dictate quick completion of the procedure, as severe hypotension, hypo-oxygenation etc.
  • patients with bleeding severity either mild or torrential according to the mentioned severity score.

研究者

发起方
Prof. Mostafa Hamad

相似试验